The glutamine metabolism antagonist, JHU083, has been shown to inhibit M.tb replication both in vitro and in vivo, improving survival, reducing lung bacterial burden, and improving lung histopathology
Approved claims will be fulfilled through a replacement of the original item only
Sakurai H, Fukudome A, Tawa R, Kito M, Takeshima S, Kimura M, Otaki N, Nakajima K, Hagino T, Kawano K, Hirai S, Suzuki S
Explore the components individually: BPC-157 research peptide and TB-500 research peptide
There is a longer list of foods, habits, and medications worth being aware of
Predicted physicochemical properties supported its hydrophobic character and oral bioavailability, suggesting it is a metabolically stable and BBB-permeable molecule [1]